← All patents

US20200030291A1

20-hete receptor (gpr75) antagonists and methods of use

University of Texas System

Abstract

The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present invention display significant potency as antagonists of 20- …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
John R. Falck
Priority date
March 09, 2016
Filing date
March 08, 2017
Publication date
January 30, 2020
Language
en
Metadata fetched
August 29, 2026 00:27